Akebia Therapeutics Cash Flow Statement (2013-2026) | AKBA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-84.30M	-59.97M	-70.42M	-64.64M	29.04M	-54.36M	-6.50M	-26.88M	-11.17M	-14.49M	0.61M	-17.98M	-8.58M	-20.04M	-22.80M	6.11M	0.25M	0.54M	-12.24M	-9.05M
Depreciation and Depletion (Quarter)							0.41M	0.40M	0.40M	0.40M	0.39M	0.36M	0.40M	0.36M	0.34M	0.31M	0.32M	0.32M	0.32M	0.33M
Share-based Compensation (Quarter)	6.51M	5.59M	4.64M	4.54M	6.92M	3.35M	3.04M	2.49M	3.49M	1.82M	1.51M	2.36M	2.07M	1.65M	1.70M	2.19M	2.68M	3.22M	3.20M	3.67M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	-2.79M	-0.58M	-0.95M	-3.97M	-6.05M	-11.02M	26.65M	2.81M			-8.18M	0.61M	-2.33M	0.86M	1.34M	-0.05M	6.98M	-1.46M	-2.26M
Asset Writedowns and Impairment (Quarter)	0.40M	1.70M	7.92M	5.34M	2.10M	2.60M			0.30M	0.70M	-1.33M	0.29M	0.50M	1.30M	-2.11M	0.16M		0.50M		3.22M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-63.14M	-56.27M	-62.81M	-21.62M	-30.66M	33.80M	-54.68M	-17.54M	3.63M	-7.17M	-2.31M	-19.43M	-10.07M	-6.70M	-4.47M	-13.59M	22.34M	28.11M	31.13M	-21.21M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	9.00M	9.00M	36.03M	9.01M	9.00M	9.00M	9.01M	9.00M	9.00M	9.00M	9.01M	9.00M	9.00M	9.00M	9.04M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.50M	0.47M	0.44M	0.42M	0.42M	0.41M	0.41M	0.40M	0.40M	0.40M	0.39M	0.36M	0.40M	0.36M	0.34M	0.31M	0.32M	0.32M	0.32M	0.33M
Change in Working Capital
Change in Receivables (Quarter)	-0.23M	14.69M	1.19M	13.78M	16.64M	-58.73M	17.02M	-21.55M	0.84M	3.02M	16.70M	-12.67M	3.15M	2.40M	3.07M	27.87M	11.53M	-6.16M	-19.10M	15.70M
Change in Inventory (Quarter)	16.52M	-0.43M	-10.34M	8.49M	-4.13M	1.00M	-24.45M	-7.35M	-3.48M	1.59M	11.78M	4.43M	14.93M	0.55M	8.50M	4.95M	7.65M	-6.90M	17.42M	2.54M
Change in Account Payables (Quarter)	3.79M	-13.81M	3.20M	-7.36M	-1.45M	-8.61M	18.92M	-9.01M	-3.04M	2.31M	4.50M	-7.50M	6.78M	-3.03M	2.39M	-2.23M	3.73M	-8.83M	10.42M	-7.79M
Change in Accured Expenses (Quarter)	-10.83M	30.80M	-37.18M	7.39M	-26.85M	-2.07M	-16.47M	-25.11M	5.73M	5.65M	3.71M	-15.04M	0.52M	-3.13M	4.88M	2.77M	16.01M	15.82M	13.93M	2.04M
Other Working Capital Changes (Quarter)	3.07M	-0.80M	15.40M	-3.19M	-5.43M	-6.20M	13.76M	0.65M	-4.39M		-8.10M	-1.41M	-2.07M	-2.99M	1.98M	1.24M	-3.89M	-3.37M	8.70M	-1.42M
Investing Activities
Capital Expenditures (Quarter)				0.11M									0.03M	0.00M	0.00M	0.02M	0.13M	0.08M	0.07M	0.06M
Sales of Property, Plant and Equipment (Quarter)																0.17M
Change in Acquisitions & Divestments (Quarter)	20.00M
Cash from Investing Activities (Quarter)	20.00M			-0.11M									-0.03M	-0.00M	-0.00M	0.15M	-0.13M	-0.08M	-7.88M	-0.06M
Financing Activities
Other financing activities (Quarter)				40.00M								0.75M		0.52M		0.06M
Cash from Financing Activities (Quarter)	37.37M	16.48M	5.40M	47.55M	-0.01M	-32.94M	-0.00M	-15.97M	-8.00M	0.05M	-1.29M	18.48M	7.64M	1.22M	22.32M	74.94M	1.72M	1.11M	-4.85M	-0.93M
Additional items
Change in Cash (Quarter)	-5.77M	-39.79M	-57.41M	25.81M	-30.67M	0.87M	-54.68M	-33.50M	-4.37M	-7.12M	-3.60M	-0.96M	-2.46M	-5.47M	17.86M	61.51M	23.94M	29.14M	18.40M	-22.20M
Free Cash Flow (Quarter)	-63.14M	-56.27M	-62.81M	-21.73M	-30.66M	33.80M	-54.68M	-17.54M	3.63M	-7.17M	-2.31M	-19.43M	-10.10M	-6.70M	-4.47M	-13.61M	22.22M	28.03M	31.06M	-21.27M
Net Cash Flow (Quarter)	-5.77M	-39.79M	-57.41M	25.81M	-30.67M	0.87M	-54.68M	-33.50M	-4.37M	-7.12M	-3.60M	-0.96M	-2.46M	-5.47M	17.86M	61.51M	23.94M	29.14M	18.40M	-22.20M

Research Tools

Akebia Therapeutics Cash Flow Statement (2013-2026) | AKBA

Create an account

Sign In

Reset Password